Literature DB >> 12419220

The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.

Alejandro Buschiazzo1, María F Amaya, María L Cremona, Alberto C Frasch, Pedro M Alzari.   

Abstract

Trans-sialidases (TS) are GPI-anchored surface enzymes expressed in specific developmental stages of trypanosome parasites like Trypanosoma cruzi, the etiologic agent of Chagas disease, and T. brucei, the causative agent of sleeping sickness. TS catalyzes the transfer of sialic acid residues from host to parasite glycoconjugates through a transglycosidase reaction that appears to be critical for T. cruzi survival and cell invasion capability. We report here the structure of the T. cruzi trans-sialidase, alone and in complex with sugar ligands. Sialic acid binding is shown to trigger a conformational switch that modulates the affinity for the acceptor substrate and concomitantly creates the conditions for efficient transglycosylation. The structure provides a framework for the structure-based design of novel inhibitors with potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419220     DOI: 10.1016/s1097-2765(02)00680-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  59 in total

Review 1.  Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles.

Authors:  Anil K Chava; Sumi Bandyopadhyay; Mitali Chatterjee; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.

Authors:  Paula A Sartor; Rosalía Agusti; Maria S Leguizamón; Oscar Campetella; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2010-04-07       Impact factor: 4.313

3.  Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.

Authors:  M Eugenia Giorgi; Laura Ratier; Rosalía Agusti; Alberto C C Frasch; Rosa M de Lederkremer
Journal:  Glycoconj J       Date:  2010-07-20       Impact factor: 2.916

4.  Free energy study of the catalytic mechanism of Trypanosoma cruzi trans-sialidase. From the Michaelis complex to the covalent intermediate.

Authors:  Gustavo Pierdominici-Sottile; Nicole A Horenstein; Adrian E Roitberg
Journal:  Biochemistry       Date:  2011-10-27       Impact factor: 3.162

5.  Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.

Authors:  Ozlem Demir; Adrian E Roitberg
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

6.  Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.

Authors:  Bill R Miller; Adrian E Roitberg
Journal:  J Mol Graph Model       Date:  2013-08-16       Impact factor: 2.518

7.  Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.

Authors:  Isadora A Oliveira; Arlan S Gonçalves; Jorge L Neves; Mark von Itzstein; Adriane R Todeschini
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

8.  Sequence and structural analysis of the Asp-box motif and Asp-box beta-propellers; a widespread propeller-type characteristic of the Vps10 domain family and several glycoside hydrolase families.

Authors:  Esben M Quistgaard; Søren S Thirup
Journal:  BMC Struct Biol       Date:  2009-07-13

Review 9.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

10.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.